diabetes header graphic


Your Hidden Weapons Of Fat Destruction:
By Shane Ellison
You have weapons of fat destruction. And you are hiding them - probably unknowingly. This explains why your waist is being overcome by enemy number one: unsightly belly fat. Are you ready to obliterate it?

As a biochemical evil-doer, belly fat slowly destroys quality of life.

Among men, it yields boobs. It keeps your soldier from standing at attention. Among women, it stores the “junk-in-the-trunk“. It smothers sex drive. It zaps life-giving energy. It disrupts mental focus.

This evil-doer is very demanding. Belly fat screams for ice-cream and soda without warning. If you don‘t yield to its desires, it holds you prisoner by making you feel edgy, light-headed, and generally pissed off until you give in.

This evil doer is a liar. Almost hourly, it tries to convince you that, “One more soda isn‘t gonna hurt you“. At night, it whispers, “Everyone in America is eating chocolate right now, you should be too“. When you wonder if you should be exercising it tries to convince you that, “Exercise is not important“.

Perhaps the most insidious characteristic of belly fat is its ability to keep you in your comfort zone -your fat comfort zone. Today, 60% of Americans are fat. Our children are following in our fat footsteps. And few people are doing anything about it. Instead, they hold tight to the myth that “carrying belly fat is genetic or a normal part of aging“. Wrong.

At 30% body fat, I reveled in my own comfort zone for an entire year before I decided to take military like action. Once I uncovered my hidden weapons of fat destruction, I descended to 11% body fat and gained about 10 lbs of muscle in 90 days and have kept it off ever since. I‘ve seen worse case scenarios do the exact same. In addition to ridding themselves and man-boobs and belly fat, some cured type II diabetes!

Forget about fad diets. Forget about fad supplements. Forget about fad drugs like Synthroid, Xenical, Meridia and the newer Accomplia that have side-effects worse than obesity. Forget about eating some exotic algae or fancy fruit drink to lose fat. If these mass produced and mass selling products were effective we wouldn?t be the fattest country in the world.

As a pharmaceutical chemist, I‘ve uncovered a trove of fat destroying weapons that would make a fat military general envious. Under the proper lifestyle and dietary circumstances the arsenal can be employed by your own body. Is Michael Moore reading?

Human Growth Hormone (hGH), Leptin, IGF-1 and Testosterone

I‘m going to spare you the biochemistry lesson. All you need to know is that in addition to being weapons of fat destruction, the above hormones are great for living young, building muscle, obtaining vibrant looking skin and ensuring that your bedroom energy is rockin‘.

Unfortunately, if you are sporting belly fat, you probably have very little of them courtesy of surging insulin levels. Insulin prevents your body from unleashing these vital fat destroyers.

The only way to get your weapons of fat destruction back on the front lines is to “increase insulin sensitivity“. Don‘t fret over the

Body's Response to Foods' Smell, Taste Could Be Diabetes Risk Factor (HealthDay)
HealthDay - THURSDAY, March 11 (HealthDay News) -- A mutation that affects how the body responds when a person smells or tastes food may play a role in the development of type 2 diabetes in some people, U.S. researchers report.
Big first trimester weight gain ups diabetes risk (Reuters)
Reuters - Women who gain weight too quickly during the first three months of pregnancy are more prone to develop pregnancy-related diabetes, new research shows.
Increasing Soda Consumption Fuels Rise in Diabetes, Heart Disease (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) --Increasing consumption of sugary soft drinks contributed to 130,000 new cases of diabetes, 14,000 new cases of heart disease and 50,000 more life-years burdened with heart disease in the last decade, a new U.S. study finds.
Processed Meat May Harm the Heart (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Conventional wisdom has dictated that fat from red meat is a risk factor for heart disease, but a new analysis from Harvard researchers finds it's eating processed meat -- not unprocessed red meat -- that increases the risk for heart disease and even diabetes.
Bugs in the gut can cause obesity: study (AFP)
AFP - The bugs that help digest food may also cause the body to pack on the pounds if they are not properly regulated, a new study has found.
Bugs in the gut can cause obesity: study (AFP)
AFP - The bugs that help digest food may also cause the body to pack on the pounds if they are not properly regulated, a new study has found.
Lunchtime coffee break best for fighting diabetes (Reuters)
Reuters - Drinking coffee cuts diabetes risk, new research confirms, but you may need to enjoy your java with lunch if you want to get any benefit.
Whole Grains Take a Bite Out of Type 2 Diabetes Risk (HealthDay)
HealthDay - WEDNESDAY, March 3 (HealthDay News) -- Brown rice is better than white rice at reducing the risk of type 2 diabetes, but whole grains are the most effective at lowering the risk, study findings show.
A1c diabetes test is a better indicator of risk (Reuters)
Reuters - A test that shows blood sugar levels over a span of several weeks is not only the best way to diagnose diabetes but also may be better at identifying who is at risk of getting diabetes than standard blood sugar tests, researchers said on Wednesday.
Newer Blood Test Predicts Diabetes, Heart Disease (HealthDay)
HealthDay - WEDNESDAY, March 3 (HealthDay News) -- The newer hemoglobin A1C test predicts diabetes as well as the traditional fasting blood sugar test, but it beats that old standard in predicting a patient's future risk of heart disease and stroke, new research shows.


science jargon, just keep reading.

Insulin sensitivity is the opposite of insulin resistance (type II diabetes). Sensitivity to insulin means that you won‘t have much of the fat storing hormone in your fat belly. You will live thin and slim.

Insensitivity to insulin means that your body is resistant to it and therefore does not use it up fast enough. As a result, your belly bathes in it. You get fat.. Simple right? Don‘t worry, medical doctors usually choke on their words when trying to explain it to patients (future drug eaters of America).

To increase insulin sensitivity, do the following:

1. If it tastes sweet spit it out. Don‘t complicate this one. I don‘t care about the mom-in-a-thong promoting the newest health/sports bar. I don‘t care about the dumb-jock on the verge of “roid-rage“ promoting a sweetened protein shake. And I don‘t care about how scrumptious that organic apple looks. If it tastes sweet spit it out. Maybe save it for birthdays. You‘ll be having many more by sticking to this rule.

2. Eat three meals per day and space them out by 4-5 hours. No snacking. Meals should be 50% healthy fat, 20% low glycemic carbs and 30% protein.

3. Key nutritional supplements can also be used. Among them are cinnamon (2-6 grams daily) and banaba leaf containing 1% corosolic acid (50-250 mg daily). The best time to use is 30-60 minutes prior to meals. These supplements are safer and more effective than any prescription drug. In fact, using “combinatorial chemistry“, drug labs are trying to make a synthetic copy-cat of both as we speak - they‘ve been failing for years.

4. Expose that white belly to God‘s healing rays! Showering 85% of your body to sunlight for 20 - 45 minutes three to five times per week will increase insulin sensitivity while controlling sugar cravings. Skin damaging sunscreen is not allowed.

5. Use my free, insulin controlling workout (sign up for my free Secret Cures eLetter above) to ensure that you pack on that dormant, sexy muscle.

Some readers will have a momentary lapse in judgment. They will continue to hide their weapons of fat destruction and instead choose to be a “drug eater of America“. This is futile and dangerous. Not a single prescription drug address - insulin sensitivity. This is the primary reason none of them reverse obesity, insulin resistance or type II diabetes. They just mask symptoms. This is a stark reminder that Mother Nature provides the best medicine.

Cute, Dimply Fat Eradicated

The above tactics will bring hGH, leptin, IGF-1 and testosterone front and center. Insulin will decrease (along with blood sugar) and your weapons of fat destruction will emerge. No matter how cute, squishy and dimply your fat might be, it will be eradicated. The shock and awe that follows will leave your peers secretly wondering, “Wow! What did they do to get rid of all that unsightly belly fat?“

But, But, But?

“But, my doctor told me to stay on my med‘s and that they would control my weight, am I supposed to get off my drugs?“

“But, I heard that Xango would cure my obesity and my toe fungus. Are you saying to stop drinking it?“

“But, I‘ve been overweight my whole life, it runs in my family.“

Stop! Don‘t say another word. Your fat cells are eating your brain. Use your hidden weapons of fat destruction before your quality of life is destroyed.

Article Source: http://www.ArticleJoe.com

Shane “The People‘s Chemist“ Ellison has an MS in organic chemistry and has first hand experience in drug design and synthesis. He is an internationally recognized authority on therapeutic nutrition and the author of Health Myths Exposed, The Hidden Truth About Cholesterol-Lowering Drugs and The AM-PM Fat Loss Discovery. Get a 10% discount on these products by visiting www.thepeopleschemist.com/foundation.html.




Here are some more diabetes articles...

Wrong Diagnosis A Common Problem
By JamesDav
Kidney stones are a very painful disease that becomes really difficult to cope up with in daily life. Kidney stones are the stones composition in the kidneys. These stones may be deposit of calcium Read more...
Diabetes - The Silent Killer
By Carol
Anyone who has the condition known as diabetes has a condition that creates a situation where the conversion of energy from the food they eat is faulty. We use glucose, which is transported Read more...

Effects of Nordic Walking and Exercise on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
<b>Conditions</b>:   Type 2 Diabetes;   Exercise<br/><b>Interventions</b>:   Behavioral: Exercise on Prescription;   Behavioral: Nordic Walking<br/><b>Sponsors</b>:   Hospital of South West Denmark;   University of Southern Denmark<br/><b>Completed</b> - verified January 2005
NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: NOX-E36;   Drug: NOX-E36<br/><b>Sponsors</b>:   Noxxon Pharma AG;   Profil Institut für Stoffwechselforschung GmbH<br/><b>Not yet recruiting</b> - verified March 2010
The Effect of a Gastric Bypass on Type 2 Diabetes in the Morbidly Obese Patient
<b>Conditions</b>:   Type 2 Diabetes;   Morbid Obesity<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   University Hospital, Gasthuisberg<br/><b>Recruiting</b> - verified March 2010
Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects
<b>Conditions</b>:   Diabetes Type 2;   Obesity<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Malmö University Hospital<br/><b>Completed</b> - verified December 2009
Biomarkers of Metabolic Syndrome and Prediabetes
<b>Conditions</b>:   Metabolic Syndrome;   Diabetes;   Prediabetes;   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   West Virginia School of Osteopathic Medicine<br/><b>Not yet recruiting</b> - verified March 2010
Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
<b>Conditions</b>:   Type 2 Diabetes;   Hypogonadism<br/><b>Intervention</b>:   Drug: Testosterone<br/><b>Sponsor</b>:   Tameside Hospital NHS Foundation Trust<br/><b>Not yet recruiting</b> - verified November 2008
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Interventions</b>:   Behavioral: Diabetes related psychological counseling and education;   Device: Continuous Glucose Monitor<br/><b>Sponsors</b>:   University Hospital Case Medical Center;   National Institute of Mental Health (NIMH)<br/><b>Not yet recruiting</b> - verified March 2010
Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: linagliptin;   Drug: placebo<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Recruiting</b> - verified March 2010
To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: AZD1656;   Drug: Gemfibrozil;   Drug: Placebo<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus
<b>Conditions</b>:   Obesity;   Bariatric Surgery;   Morbid Obesity;   Diabetes Mellitus Type 2;   Diet Therapy<br/><b>Interventions</b>:   Procedure: Roux-en-Y Gastric Bypass;   Behavioral: Caloric Restriction<br/><b>Sponsor</b>:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified February 2010
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: AZD1656;   Drug: Pioglitazone<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Recruiting</b> - verified March 2010
The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Canagliflozin 100 mg;   Drug: Placebo/sitagliptin 2x50 mg;   Drug: Canagliflozin 300 mg<br/><b>Sponsor</b>:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.<br/><b>Recruiting</b> - verified March 2010
Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: INSULIN GLARGINE;   Drug: INSULIN GLULISINE<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Lifestyle Intervention to Limit Excessive Weight Gain During Pregnancy in Minority Women
<b>Conditions</b>:   Pregnancy;   Weight Gain<br/><b>Interventions</b>:   Behavioral: Lifestyle Intervention group;   Behavioral: Standard of Care<br/><b>Sponsor</b>:   Emory University<br/><b>Not yet recruiting</b> - verified March 2010
Comparing Google With A Focused Diabetes Search Engine
<b>Condition</b>:   Diabetes<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Beth Israel Deaconess Medical Center<br/><b>Recruiting</b> - verified March 2010
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetic Vascular Complications<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Winthrop University Hospital<br/><b>Recruiting</b> - verified March 2010
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: NN1250;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
<b>Conditions</b>:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy<br/><b>Interventions</b>:   Drug: SB-509;   Other: Saline<br/><b>Sponsors</b>:   Sangamo Biosciences;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified March 2010
A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians
<b>Conditions</b>:   Diabetes;   Obesity<br/><b>Intervention</b>:   Behavioral: Lifestyle Intervention Classes<br/><b>Sponsors</b>:   Emory University;   American Diabetes Association;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified January 2010
Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II
<b>Conditions</b>:   Diabetes;   Cataract<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Frederiksberg University Hospital<br/><b>Completed</b> - verified August 2009
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Abbott<br/><b>Completed</b> - verified March 2010
Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   Other: Computerized reminders on hypertension intensification<br/><b>Sponsors</b>:   Brigham and Women's Hospital;   Robert Wood Johnson Foundation<br/><b>Not yet recruiting</b> - verified March 2010
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia
<b>Conditions</b>:   Diabetes;   Limb Ischemia<br/><b>Interventions</b>:   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.<br/><b>Sponsors</b>:   Fundacion Progreso y Salud, Spain;   Carlos III Health Institute<br/><b>Recruiting</b> - verified January 2010
Reducing HIV Risk Among Mexican Youth
<b>Conditions</b>:   HIV/AIDS;   STD;   Sexual Behavior<br/><b>Interventions</b>:   Behavioral: Adolescent Safer Sex Intervention;   Behavioral: Parent Safer Sex Communication Intervention;   Other: Adolescent Health Promotion Control Condition;   Other: Parent Health Promotion Control Condition<br/><b>Sponsors</b>:   University of Michigan;   National Institute of Nursing Research (NINR)<br/><b>Completed</b> - verified March 2010
Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects
<b>Conditions</b>:   Genotype;   Pharmacokinetic<br/><b>Intervention</b>:   Drug: Glipizide<br/><b>Sponsors</b>:   Chinese Academy of Sciences;   The First Affiliated Hospital of Lanzhou University<br/><b>Completed</b> - verified November 2009
Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
<b>Condition</b>:   Non-Alcoholic Fatty Liver Disease<br/><b>Interventions</b>:   Drug: Galvus (vitagliptin);   Drug: Galvus + vitamin D<br/><b>Sponsor</b>:   Ziv Hospital<br/><b>Not yet recruiting</b> - verified March 2010
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
<b>Condition</b>:   Diabetic Peripheral Neuropathy<br/><b>Interventions</b>:   Other: Skin biopsy;   Other: Skin biopsy<br/><b>Sponsors</b>:   Albany Medical College;   Endo Pharmaceuticals<br/><b>Recruiting</b> - verified March 2010
Adolescent Cooking and Eating Study
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   Behavioral: Nutrition Education, Dietary Counseling, and Cooking<br/><b>Sponsors</b>:   Children's Hospital Boston;   Thrasher Research Fund<br/><b>Not yet recruiting</b> - verified March 2010
Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
<b>Conditions</b>:   Diabetes Mellitus 1 or 2;   Midfoot Charcot Neuroarthropathy<br/><b>Interventions</b>:   Procedure: Surgery with Midfoot Fusion Bolt;   Procedure: Cast treatment<br/><b>Sponsor</b>:   AO Clinical Investigation and Documentation<br/><b>Not yet recruiting</b> - verified March 2010
An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   Drug: repaglinide<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified February 2010
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
<b>Condition</b>:   Diabetic Macular Edema<br/><b>Interventions</b>:   Drug: Ranibizumab;   Drug: ranibizumab<br/><b>Sponsors</b>:   Johns Hopkins University;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified February 2010
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
<b>Conditions</b>:   Schizophrenia;   Schizoaffective Disorders;   Schizophreniform Disorders<br/><b>Interventions</b>:   Drug: Pravastatin;   Drug: Placebo<br/><b>Sponsors</b>:   Massachusetts General Hospital;   Stanley Medical Research Institute<br/><b>Not yet recruiting</b> - verified March 2010
Healthy Homes/Healthy Kids_5-9
<b>Conditions</b>:   Obesity;   Injury<br/><b>Interventions</b>:   Behavioral: Healthy Eating/Physical Activity;   Behavioral: Safety/Injury Prevention<br/><b>Sponsors</b>:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Washington;   University of Minnesota School of Public Health<br/><b>Not yet recruiting</b> - verified March 2010
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Abbott;   McKesson Canada<br/><b>Recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>:   Healthy Volunteers<br/><b>Interventions</b>:   Dietary Supplement: Single High Dose Cholecalciferol;   Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>:   Mayo Clinic<br/><b>Recruiting</b> - verified March 2010
Effects of N-acetylcysteine on Diabetic Foot Oxygenation
<b>Condition</b>:   Foot Ulcer, Diabetic<br/><b>Intervention</b>:   Drug: N-acetylcysteine<br/><b>Sponsor</b>:   University of Turin, Italy<br/><b>Completed</b> - verified February 2010
Self Management and Reminders With Technology: SMART Appraisal of an Integrated Personal Health Record (PHR)
<b>Condition</b>:   Cardiovascular Risk<br/><b>Interventions</b>:   Other: SMART PHR;   Other: usual care<br/><b>Sponsors</b>:   University of Pittsburgh;   Agency for Healthcare Research and Quality (AHRQ)<br/><b>Not yet recruiting</b> - verified March 2010
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicines.
<b>Condition</b>:   Acute Gout<br/><b>Interventions</b>:   Drug: ACZ885;   Drug: Triamcinolone acetonide<br/><b>Sponsor</b>:   Novartis Pharmaceuticals<br/><b>Not yet recruiting</b> - verified March 2010
Healthy Homes/Healthy Kids Preschool
<b>Condition</b>:   Obesity<br/><b>Interventions</b>:   Behavioral: Busy Bodies/Better Bites;   Behavioral: Healthy Spots/Safe Tots<br/><b>Sponsors</b>:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified March 2010
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
<b>Condition</b>:   Esophageal Varices<br/><b>Intervention</b>:   Device: Capsule endoscopy, Esophagogastroduodenoscopy<br/><b>Sponsors</b>:   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified June 2008
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
<b>Condition</b>:   Colitis, Ischemic<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified December 2009